Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery

Exclusion Criteria

• •Those who have a history of severe drug allergy or are allergic to the drugs in this study;
• •Those with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney, and hematological system;
• •Combined with parathyroid disease or other calcium and phosphorus metabolism-related diseases;
• •Benign thyroid lesions;
• •Received mitoxantrone treatment within 4 weeks;
• •Enrolled in other clinical studies at the same time;
• •Known history of psychotropic drug abuse, alcohol abuse or drug abuse;
• •Pregnant or lactating women;
• •According to the investigator's judgment, the subject has other factors that may cause him to be forced to terminate the study midway, such as suffering from other serious diseases (including mental illness) requiring combined treatment, serious abnormal laboratory examination values, family or social factors, which may affect the safety of the subject or the collection of trial data.